Announcements Trials
Browse Landscape Eligibility

Clinical Trials

26 trials
RecentStart dateEnrollment
Edema × Clear all

Phase

Phase NA 11Phase 3 4Phase 2 2Phase 4 1Phase 1/2 1

Status

Completed 10Active not recruiting 4Withdrawn 3Unknown 3Not yet recruiting 3Recruiting 2Terminated 1

Sponsor Class

OTHER 21INDUSTRY 5

Study Type

Interventional 19Observational 7

Sponsor

Cancer Type

Breast 9CNS 5Other hematologic neoplasm 2Thoracic 1Other 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Breast Neoplasms 10998Neoplasms 8807Carcinoma, Non-Small-Cell Lung 5711Prostatic Neoplasms 5278Colorectal Neoplasms 4951Lung Neoplasms 4210Pancreatic Neoplasms 3003Multiple Myeloma 3001Neoplasm Metastasis 2954Leukemia, Myeloid, Acute 2927Carcinoma, Hepatocellular 2734Ovarian Neoplasms 2657Melanoma 2635Stomach Neoplasms 2567Lymphoma 2502Head and Neck Neoplasms 2162Recurrence 2132Precursor Cell Lymphoblastic Leukemia-Lymphoma 2069Leukemia 1992Brain Neoplasms 1971Colonic Neoplasms 1939Lymphoma, Non-Hodgkin 1894Rectal Neoplasms 1846Uterine Cervical Neoplasms 1806Glioblastoma 1699Leukemia, Lymphocytic, Chronic, B-Cell 1663Carcinoma, Renal Cell 1597Squamous Cell Carcinoma of Head and Neck 1550Lymphoma, Follicular 1526Esophageal Neoplasms 1516

Interventions

Corticotropin-Releasing Hormone 4pembrolizumab 1Tranexamic Acid 1Taxes 1Surgical Procedures, Operative 1Panitumumab 1Paclitaxel 1Manual Lymphatic Drainage 1Losartan 1Furosemide 1Exercise 1Electric Stimulation 1Carboplatin 1Athletic Tape 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT07443618 2026-03-02

Measuring Fluid Buildup in Cancer Patients

University of Copenhagen

Not yet recruiting
46 enrolled

Edema, Lymphedema, Neoplasms

NCT07365618 2026-01-26

LymFit

Faculdade de Motricidade Humana

Phase NA Not yet recruiting
58 enrolled
Breast

Breast Cancer Lymphedema, Breast Neoplasms, Edema, Motor Activity

NCT02411656 2026-01-23

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
71 enrolled 11 charts
Breast

Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02876107 2025-10-10

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
42 enrolled
Breast

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07070973 2025-08-11

HEMOPEC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Not yet recruiting
52 enrolled
Gynecologic

Edema, Ovarian Neoplasms

NCT05142800 2025-05-22

Screening For BCRL In Targeted Therapy For Breast Cancer

Massachusetts General Hospital

Active not recruiting
166 enrolled
Breast

Breast Cancer Lymphedema, Breast Neoplasms, Edema, Lymphedema

NCT04606030 2025-03-11

LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)

Fibralign Corporation

Phase NA Recruiting
60 enrolled

Edema, Lymphedema

NCT05992246 2025-02-04

The Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children

Tanta University

Completed
85 enrolled
LymphoidOther hematologic neoplasm

Edema, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05797649 2024-11-13

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Chinese University of Hong Kong

Recruiting
120 enrolled
Thoracic

Edema, Fibrosis, Heart Failure, Infections, Neoplasms, Pleural Effusion, Tuberculosis, Hypoalbuminemia, Renal Insufficiency

NCT05104528 2024-01-17

Non-Invasive Cardiometry and Ultrasound Guided Inferior Vena Cava Collapsibility Index in Assessing Fluid Responsiveness

National Cancer Institute, Egypt

Phase NA Completed
43 enrolled

Edema, Neoplasms, Critical Illness, Sepsis

NCT03580213 2023-09-22

Hand Therapy or Not Following Collagenase Treatment for Dupuytren's Contracture?

Haukeland University Hospital

Phase NA Completed
72 enrolled

Cicatrix, Dupuytren Contracture, Edema

NCT02306538 2023-02-14

EMBRACE-MRI

University Health Network, Toronto

Active not recruiting
180 enrolled
Breast

Breast Neoplasms, Cicatrix, Edema, Inflammation

NCT02734979 2022-10-27

Biobridge

Stanford University

Phase NA Completed
1 enrolled 10 charts

Edema, Lymphedema

NCT04907812 2021-06-01

THAW

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 4 Unknown
50 enrolled

Wrist Fractures, Disease, Dupuytren Contracture, Edema, Hand Injuries

NCT01805453 2020-05-08

ASTER

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
80 enrolled
CNS

Edema, Glioblastoma

NCT02470221 2019-05-31

Goal-directed Intraoperative Fluid Therapy in High-risk Surgery

Peking Union Medical College Hospital

Completed
600 enrolled

Edema, Postoperative Complications

NCT03559296 2018-08-23

Reliability of Subcutaneous Echogenicity (SEG) Grade and Subcutaneous Echo-free Space (SEFS) Grade

Marmara University

Completed
50 enrolled
Breast

Breast Cancer Lymphedema, Edema

NCT03477565 2018-03-26

BREASTAPE

IRCCS San Raffaele

Phase NA Unknown
60 enrolled
Breast

Breast Neoplasms, Edema, Seroma

NCT02158832 2017-08-30

Acupuncture for Lymphedema Secondary to Breast Cancer Treatment

McMaster University

Phase NA Withdrawn
Breast

Breast Neoplasms, Edema, Lymphedema, Neoplasms

NCT02707835 2016-03-17

Edema Control in Patients With Breast Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia Taping

National Taiwan University Hospital

Phase NA Unknown
90 enrolled
Breast

Breast Neoplasms, Edema

NCT00088166 2014-08-13

XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors

Celtic Pharma Development Services

Phase 3 Completed
200 enrolled 17 charts
CNS

Astrocytoma, Brain Edema, Brain Neoplasms, Edema

NCT01369121 2013-07-30

Tolerability Study of Xerecept® in Pediatric Patients

Celtic Pharma Development Services

Phase 1/2 Terminated
15 enrolled
CNS

Brain Edema, Brain Neoplasms, Edema

NCT01508260 2013-04-05

Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

M.D. Anderson Cancer Center

Phase NA Withdrawn
OtherOther hematologic neoplasm

Hypoxia, Dyspnea, Dyspnea, Paroxysmal, Edema, Leukemia, Respiratory Sounds

NCT00226655 2012-08-31

An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies

Celtic Pharma Development Services

Phase 3 Completed
112 enrolled 8 charts
CNS

Astrocytoma, Brain Edema, Brain Neoplasms, Edema

NCT00226668 2008-01-03

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Celtic Pharma Development Services

Phase 3 Withdrawn
120 enrolled
CNS

Astrocytoma, Brain Edema, Brain Neoplasms, Edema

NCT00441662 2007-03-01

Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema

Wills Eye

Phase NA Completed
170 enrolled
Dermatologic

Edema, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡